近日,来自新加坡国立大学的研究者们在Cancer research杂志上发表了题为“Targeting RNA exonuclease XRN1 potentiates efficacy of cancer immunotherapy”的文章,该研究发现为开发XRN1抑制剂并探索其与癌症免疫治疗相结合的潜在临床应用提供了分子基础。
Xue-Bin Ran et al. Targeting RNA exonuclease XRN1 potentiates efficacy of cancer immunotherapy. Cancer Res. 2023 Jan 13;CAN-21-3052. doi: 10.1158/0008-5472.CAN-21-3052.